v3.26.1
Discontinued Operations - Schedule of Disposal Groups (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses        
(Gain) loss on assets held for sale     $ 9,491 $ 92,706
Income (loss) from discontinued operations, net of tax $ 3,985 $ (47,655) (10,034) (79,445)
B Medical Systems Business | Discontinued Operations, Held-for-Sale        
Revenue        
Total revenue 10,700 16,302 46,596 51,099
Cost of revenue        
Total cost of revenue 8,830 11,393 35,786 37,654
Gross profit 1,870 4,909 10,810 13,445
Operating expenses        
Research and development 1,301 1,533 4,024 4,369
Selling, general and administrative 3,538 6,939 12,441 20,855
(Gain) loss on assets held for sale (6,474) 60,858 9,491 92,706
Restructuring charges 135 373 434 1,051
Total operating (income) expenses (1,500) 69,703 26,390 118,981
Operating income (loss) 3,370 (64,794) (15,580) (105,536)
Interest income (expense), net 0 (10) 1 (20)
Other income (expense), net 65 (92) 1,231 (166)
Income (loss) before income taxes 3,435 (64,896) (14,348) (105,722)
Income tax expense (benefit) 1,163 (17,542) (3,138) (26,959)
Income (loss) from discontinued operations, net of tax 2,272 (47,354) (11,210) (78,763)
B Medical Systems Business | Discontinued Operations, Held-for-Sale | Products        
Revenue        
Total revenue 9,249 14,333 39,529 44,507
Cost of revenue        
Total cost of revenue 5,671 9,793 26,937 31,333
B Medical Systems Business | Discontinued Operations, Held-for-Sale | Services        
Revenue        
Total revenue 1,451 1,969 7,067 6,592
Cost of revenue        
Total cost of revenue $ 3,159 $ 1,600 $ 8,849 $ 6,321